Starting 01 July 2024, Payment via over-the-counter using LBP Oncoll Deposit Slip will be temporarily suspended until further notice.
During this period, FDA encourages all concerned parties to utilize the following payment channels:
- LBP LinkBiz Portal
- DBP BancNet Bills Payment
- Over the Counter (for applications included in the Annexes of FDA Advisory No. 2024-0320)
Furthermore, the FDA observed issues with pending applications from 2023 and below. Some applications may not have proceeded to the next steps, particularly the “Payment” task, due to the “No Records Found”. Applicants affected by this issue are requested to verify their pending applications and check if they have yet to proceed to the “Payment” task or were not yet completed. Affected parties are requested to fill out the following form completely and correctly to facilitate the verification of payment: https://forms.gle/kx8MUtEZLBqVVceJ6
For more information, click here.
If you have any queries about this draft guidance, please contact us at sales@andamanmed.com or click the button below.